XARELTO 1 mg/ml, granules for supension oral bottle, 100 ml
Brand page: Xarelto (rivaroxaban) — all forms and strengths in France
Active ingredients: Rivaroxaban
Commercialized according to BDPMDispensing in France: Prescription only
Granules for oral suspensionbottle, 100 mlorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- XARELTO 1 mg/mL, granulés pour supension buvable
- Pharmaceutical form
- granulés pour suspension buvable
- Route of administration
- orale
- Presentation description
- 1 flacon en verre de 100 mL (2,625g) avec fermeture de sécurité enfant + 2 seringues bleues de 1 mL + 1 seringue de 50 mL + 1 adaptateur (Enfants de moins de 4 kg)
- Marketing authorisation holder
- BAYER AG (ALLEMAGNE)
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 Apr 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
66751738CIP73021985CIP133400930219850Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| RIVAROXABANgranulés | 1 mg · 1 mL de solution après reconstitution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.